MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Balance Sheets Overview

Current Ratio
1021.35%
Quick Ratio
1021.35%
Cash Ratio
150.78%
Debt to Asset Ratio
20.13%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities - short te...
    • Cash and cash equivalents
    • Prepaid and other current assets
    • Others
Liabilities Breakdown
    • Common shares, no par value unli...
    • Accumulated deficit
    • Additional paid-in capital
    • Others
Balance Sheets
2026-07-31
2026-04-30
2026-01-31
2025-10-31
Cash and cash equivalents
41,025
29,827
36,613
50,152
Marketable securities - short term
225,295
228,638
239,335
143,584
Restricted investments
79
75
74
79
Investment tax credits receivable
975
822
1,197
927
Prepaid and other current assets
10,526
10,638
11,997
6,649
Total current assets
277,900
270,000
289,216
201,391
Marketable securities - long term
0
26,709
36,601
8,522
Property and equipment, net
2,156
2,335
2,441
2,477
Operating lease right of use asset
6,877
7,105
7,470
7,716
Other assets
1,389
1,375
1,385
1,362
Total assets
288,322
307,524
337,113
221,468
Accounts payable
2,541
1,793
2,435
6,688
Accrued expenses and other current liabilities
22,220
17,212
19,668
15,275
Operating lease liabilities, current
2,249
2,287
2,318
2,014
Current portion of note payable
199
193
188
8,002
Total current liabilities
27,209
21,485
24,609
31,979
Note payable, net of current portion
25,155
24,910
24,736
15,324
Operating lease liabilities, net of current portion
5,668
5,961
6,222
6,455
Liabilities, total
58,032
52,356
55,567
53,758
Common shares, no par value unlimited shares authorized, 67,014,067 and 52,018,658 shares issued and outstanding as of july 31, 2026 and october 31, 2025, respectively
632,021
631,995
631,992
513,281
Additional paid-in capital
64,132
56,325
52,180
27,349
Accumulated other comprehensive loss
-1,351
-1,141
-842
-888
Accumulated deficit
-464,512
-432,011
-401,784
-372,032
Total shareholder's equity
230,290
255,168
281,546
167,710
Total liabilities and shareholders' equity
288,322
307,524
337,113
221,468
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

ENGN Balance Sheet Sankey DiagramSankey diagram visualizing ENGN balance sheet for the periodMarketable securities -short term$225,295K (33.08%↑ Y/Y)Cash and cashequivalents$41,025K (25.75%↑ Y/Y)Prepaid and othercurrent assets$10,526K (22.14%↑ Y/Y)Investment tax creditsreceivable$975K (37.52%↑ Y/Y)Restricted investments$79K (9.72%↑ Y/Y)Total current assets$277,900K (31.51%↑ Y/Y)Operating lease right ofuse asset$6,877K (-13.70%↓ Y/Y)Property and equipment,net$2,156K (14.74%↑ Y/Y)Other assets$1,389K (0.73%↑ Y/Y)Total assets$288,322K (17.42%↑ Y/Y)Total liabilities andshareholders' equity$288,322K (17.42%↑ Y/Y)Total shareholder'sequity$230,290K (14.76%↑ Y/Y)Liabilities, total$58,032K (29.31%↑ Y/Y)Accumulated deficit-$464,512K (-39.01%↓ Y/Y)Accumulated othercomprehensive loss-$1,351K (-11.75%↓ Y/Y)Common shares, no parvalue unlimited...$632,021K (23.89%↑ Y/Y)Total currentliabilities$27,209K (33.12%↑ Y/Y)Note payable, net ofcurrent portion$25,155K (42.07%↑ Y/Y)Operating leaseliabilities, net of current...$5,668K (-15.81%↓ Y/Y)Additional paid-in capital$64,132K (147.91%↑ Y/Y)Accrued expenses andother current...$22,220K (99.87%↑ Y/Y)Accounts payable$2,541K (6.59%↑ Y/Y)Operating leaseliabilities, current$2,249K (47.28%↑ Y/Y)Current portion of notepayable$199K (-96.32%↓ Y/Y)

enGene Therapeutics Inc. (ENGN)

enGene Therapeutics Inc. (ENGN)